Variant report
Variant | nsv517658 |
---|---|
Chromosome Location | chr3:160681614-160684720 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1562464 | chr3:160681614-160681615 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs571543549 | chr3:160681632-160681633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs16831667 | chr3:160681644-160681645 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs190257135 | chr3:160681688-160681689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7356038 | chr3:160681716-160681717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs368190556 | chr3:160681717-160681718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7356039 | chr3:160681722-160681723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571074247 | chr3:160681730-160681731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531623053 | chr3:160681771-160681772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150262270 | chr3:160681891-160681892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs112490452 | chr3:160681940-160681941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534304478 | chr3:160681970-160681971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554197059 | chr3:160681980-160681981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1447608 | chr3:160682019-160682020 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs138903901 | chr3:160682055-160682056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556469888 | chr3:160682058-160682059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs557131390 | chr3:160682079-160682080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs62280331 | chr3:160682092-160682093 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs545273212 | chr3:160682094-160682095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs145984260 | chr3:160682103-160682104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs77094903 | chr3:160682106-160682107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557350693 | chr3:160682111-160682112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs541601978 | chr3:160682182-160682183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577181541 | chr3:160682187-160682188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539946369 | chr3:160682191-160682192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs74596047 | chr3:160682221-160682222 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533842907 | chr3:160682328-160682329 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542844322 | chr3:160682330-160682331 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185651286 | chr3:160682409-160682410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs115250037 | chr3:160682415-160682416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531661458 | chr3:160682435-160682436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551666985 | chr3:160682443-160682444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs149392108 | chr3:160682499-160682500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs1868109 | chr3:160682500-160682501 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs547471987 | chr3:160682526-160682527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375526123 | chr3:160682595-160682596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs11709802 | chr3:160682599-160682600 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs115516169 | chr3:160682600-160682601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190583735 | chr3:160682618-160682619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs180817720 | chr3:160682619-160682620 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs185454502 | chr3:160682623-160682624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372069184 | chr3:160682627-160682628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572404505 | chr3:160682635-160682636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539884914 | chr3:160682650-160682651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs144739274 | chr3:160682664-160682665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573710843 | chr3:160682699-160682700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114633880 | chr3:160682713-160682714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs545329832 | chr3:160682770-160682771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531494553 | chr3:160682802-160682803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112833956 | chr3:160682819-160682820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 21811512 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:160667400-160696000 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
2 | chr3:160670200-160686600 | Weak transcription | Fetal Muscle Leg | muscle |
3 | chr3:160670400-160686400 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
4 | chr3:160670400-160700400 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
5 | chr3:160670600-160682200 | Weak transcription | Left Ventricle | heart |
6 | chr3:160678400-160697600 | Weak transcription | Primary T cells from cord blood | blood |
7 | chr3:160679000-160686600 | Weak transcription | Colon Smooth Muscle | Colon |
8 | chr3:160680000-160683600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr3:160680000-160684400 | Weak transcription | Dnd41 | blood |
10 | chr3:160681000-160686600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr3:160681600-160684800 | Weak transcription | Primary hematopoietic stem cells | blood |
12 | chr3:160682200-160682400 | Strong transcription | Left Ventricle | heart |
13 | chr3:160682400-160686600 | Weak transcription | Left Ventricle | heart |
14 | chr3:160683600-160684800 | ZNF genes & repeats | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr3:160683800-160687000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
16 | chr3:160684400-160684600 | ZNF genes & repeats | Dnd41 | blood |
17 | chr3:160684400-160685200 | ZNF genes & repeats | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
18 | chr3:160684600-160685400 | ZNF genes & repeats | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
19 | chr3:160684600-160689200 | Weak transcription | Dnd41 | blood |